OBJECTIVE:The purpose of this report is to establish whether USgHIFU ablation can be considered an effective and enhancing auxiliary therapy when treating patients with malignant soft tissue tumors of
Introduction: Malignant liver tumors have a very poor prognosis.Primary hepatocelular carcinoma (HCC) is usually fatal with less than 5% of patients surviving 5 years after diagnosis.
Purpose: High intensity focused ultrasound (HIFU) has been reported to be beneficial to patients with late stage HCC when combining with TACE, by which the one-year survival reached 42.9%.
Objective To study the efficacy, prognosis and safety of high-intensity focused ultrasound (HIFU) combined with transcatheter arterial chemoembolization (TACE) in the treatment of hepatocellular carci
Introduction: Pancreatic cancer (PC) patients have poor prognosis.Most pancreatic tumors are metastatic or unresectable in the time of diagnosis.In this stage the choice of treatment is restricted to
HIFU-therapy is a high-technology method of local treatment of human tumors based on influence of high-intensive focused ultrasound waves without damage to skin tissues and organs.
Purpose: To explore the value of contrast-enhanced ultrasound to the dosage control and therapeutic efficacy of HIFU Methods: A total of 65 patients with clinically confirmed uterine fibroid or adenom
Purpose: To study the effectiveness of ultrasound contrast enhancing agent Sonazoid in HIFU treatment Methods: A retrospective analysis has been conducted on 40 patients with uterine fibroids.
Purpose: To investigate the potential mechanisms and the clinical efficacy of HIFU in the treatment of non-malignant vulvar diseases Methods: From July 2006 to January 2012, 1126 patients have been di